Palantir Technologies heads into the final two weeks before its August 3 earnings print with a clear data shift: the short sellers who spent two months building their largest position of the year are now quietly paring back, even as the stock itself drifts lower.
The turn in short interest is the week's most concrete development. SI peaked at 4.15% of free float on July 15 — the highest sustained reading in at least a year, up from roughly 2.3% in late April — and has since pulled back to 3.74%, a 4.4% decline on the week. That reversal is small in absolute terms but meaningful in context: bears were adding into a rising stock for months, and the first sign of retreat coincides with the price softening to $132.66, down 1.6% on the day and off 0.8% on the week. Whether this is profit-taking or a genuine change of view, the crowding that prior notes flagged as the defining feature of PLTR's positioning is now, at the margin, unwinding. Borrow conditions remain entirely friction-free — cost to borrow has eased further to 0.36%, down 9% on the week, and availability is exceptionally loose at 8,801% of short interest, meaning there are nearly ninety shares available for every one currently borrowed. No mechanical pressure is forcing anyone's hand; this is a discretionary reduction.
Options traders have nudged slightly more bullish relative to their own recent baseline. The put/call ratio has fallen to 0.92, just over one standard deviation below its 20-day average of 0.95. That is a modest move, not a dramatic signal, and it sits comfortably within the year's range of 0.61 to 1.16. The cleaner read from the options market is what it is doing — there is no defensive spike, no unusual hedging surge into the August 3 print. Positioning looks calm rather than charged.
The Street remains deeply divided, and the valuation debate is the core of it. Bulls at Wedbush and Rosenblatt carry targets of $225–$230, well above the current price. DA Davidson upgraded to Buy earlier this month, lifting its target to $175. Against that, RBC Capital maintains an Underperform with a $90 target, and the consensus sits at Hold with a mean target around $185. The forward PE of 73x and EV/EBITDA of 53x have both compressed modestly over the past month as the stock pulled back, but they remain at levels where any earnings disappointment is hard to absorb. The bear case — as articulated by the more sceptical analysts — centres precisely on that valuation alongside geopolitical risk and limited shareholder voting rights. The bull case rests on AI platform dominance and accelerating commercial revenue. Earnings history adds texture to the risk: the last two prints produced first-day declines of 5.7% and 6.9%, with five-day losses of 5% and 14% respectively. The market has not been kind to PLTR on results day.
Insider activity is worth noting, though not alarming. CTO Shyam Sankar sold $24 million of stock on July 2, and director Alex Moore has made a series of smaller sales through June and July. The 90-day net is technically positive at around $100 million due to option-related activity, but the recent direction of discretionary selling is one-way. Insiders are not buying the dip.
Peers provide useful context on the week's broader tape. NOW fell 2.7% on the week, CLBT dropped 8.8%, and ZETA lost 6% — suggesting the application software group has been broadly under pressure, so PLTR's flat-to-down week is not an isolated story. MSFT bucked the trend with a 3.3% gain, a reminder that the AI narrative is not uniformly weak, just selectively punished where valuations are hardest to defend.
August 3 is now the only thing that matters for positioning — whether the modest short-covering this week accelerates, stalls, or reverses entirely will likely depend on whether Palantir can produce a result that justifies a price the market is already debating at length.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
